Verrica Pharmaceuticals (VRCA) Change in Account Payables (2021 - 2025)
Historic Change in Account Payables for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to -$736000.0.
- Verrica Pharmaceuticals' Change in Account Payables fell 33550.3% to -$736000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $620000.0, marking a year-over-year increase of 16731.81%. This contributed to the annual value of -$568000.0 for FY2024, which is 12580.65% down from last year.
- Latest data reveals that Verrica Pharmaceuticals reported Change in Account Payables of -$736000.0 as of Q3 2025, which was down 33550.3% from $878000.0 recorded in Q2 2025.
- Verrica Pharmaceuticals' Change in Account Payables' 5-year high stood at $1.5 million during Q2 2023, with a 5-year trough of -$1.4 million in Q2 2024.
- Over the past 5 years, Verrica Pharmaceuticals' median Change in Account Payables value was $52000.0 (recorded in 2024), while the average stood at $77947.4.
- Per our database at Business Quant, Verrica Pharmaceuticals' Change in Account Payables soared by 158000.0% in 2022 and then plummeted by 97115.38% in 2025.
- Over the past 5 years, Verrica Pharmaceuticals' Change in Account Payables (Quarter) stood at -$25000.0 in 2021, then soared by 1580.0% to $370000.0 in 2022, then soared by 56.22% to $578000.0 in 2023, then surged by 61.07% to $931000.0 in 2024, then tumbled by 179.05% to -$736000.0 in 2025.
- Its Change in Account Payables was -$736000.0 in Q3 2025, compared to $878000.0 in Q2 2025 and -$453000.0 in Q1 2025.